AI-enabled drug discovery platform designing small‑molecule therapeutics for the aging brain and CNS disorders. Integrates medicinal chemistry, biology, pharmacology and toxicology to generate development‑ready compounds that prioritize clinical success by identifying molecular signals linked to clinical failure.